Mylan has launched a generic version of a drug made by Pfizer for treating bladder problems, the company said Tuesday.
Teva Pharmaceutical Industries has launched an authorized generic version of a drug used to treat overactive bladder, the company said Friday.
The Food and Drug Administration has approved a generic drug made by Mylan for treating overactive bladder, according to agency records.
Generic drug maker Mylan has settled a patent litigation suit with Pfizer concerning a drug for treating bladder disorders, Mylan said Friday.
A drug made by Pfizer and used to treat overactive bladder was effective in reducing leakage of urine in patients with the disorder, according to the results of a post-approval clinical study.
Pfizer has filed suit against generic drug maker Impax Labs in connection with the latter’s attempt to market a generic drug for bladder problems.
The world of generic drugs has a big year ahead of it. Actually, it has...
The often wide gap between what consumers will pay out of pocket for a branded...